Clinical Trials Logo

Myopia clinical trials

View clinical trials related to Myopia.

Filter by:

NCT ID: NCT04585646 Completed - Myopia Clinical Trials

A Two-Week Crossover Dispensing Evaluation Of Orion Daily Wear Soft Contact Lens

Start date: September 14, 2020
Phase: N/A
Study type: Interventional

The primary objective of the study is to evaluate the clinical performance of test lens (Orion) in comparison with control lens (Gemini) over a period of two weeks of wear.

NCT ID: NCT04536571 Completed - Myopia Clinical Trials

Vision Stability and Preference for Soft Toric vs. Soft Spherical Contact Lenses

Start date: September 3, 2020
Phase: N/A
Study type: Interventional

The principal hypothesis is to be tested in this work is that vision stability (the primary outcome measure) with a spherical contact lens correction vs. a toric contact lens correction will be the same.

NCT ID: NCT04528017 Completed - Myopia Clinical Trials

Clinical Comparison of 2 Daily Disposable Contact Lenses - Pilot Study 2

Start date: September 1, 2020
Phase: N/A
Study type: Interventional

The primary objective of this study is to evaluate the overall performance of PRECISION1 contact lenses when compared to Clariti 1-Day contact lenses.

NCT ID: NCT04527978 Completed - Myopia Clinical Trials

Clinical Comparison of 2 Daily Disposable Contact Lenses - Pilot Study 1

Start date: September 15, 2020
Phase: N/A
Study type: Interventional

The primary objective of this study is to evaluate the overall performance of PRECISION1 contact lenses when compared to Biotrue ONEday contact lenses.

NCT ID: NCT04524910 Completed - Clinical trials for Myopic Choroidal Neovascularization

A Study to Learn More About How Drug Aflibercept Works in Canadian Patients With Reduced Vision Caused by New Blood Vessels Growing in the Eye (Myopic Choroidal Neovascularization or mCNV)

REALM
Start date: June 16, 2021
Phase:
Study type: Observational

Being short sighted means that vision is blurry when looking at things far away. People with a condition called "pathologic myopia" are short sighted due to problems in the back layer of their eyes, also known as the retina. Some people with pathologic myopia can develop a serious condition called myopic choroidal neovascularization (mCNV). In people with mCNV, new blood vessels grow into the retina. These blood vessels can break, leaking blood or fluid into the retina. This can cause blurry vision or a loss of vision. In this study, researchers will find out more about how well drug aflibercept works and how safe it is in Canadian patients with mCNV. The researchers in this study will review information from the patients' eye doctor visits. The patients in this study will include Canadian men and women who started receiving aflibercept between May 2017 and August 2019. These patients were at least 18 years old and had not received treatment for their mCNV before. The researchers will look at the results of vision tests to find out how well the patients could read from a distance after they received aflibercept for 6 months. They will compare the results of these tests to before the patients received treatment. They will also learn more about how safe it is to have aflibercept injection into the eye.

NCT ID: NCT04492397 Completed - Myopia Clinical Trials

Comparing The Performance Of Two Different Daily Disposable Lenses (MIKI)

Start date: September 30, 2020
Phase: N/A
Study type: Interventional

The objective of the study is to evaluate and compare the performance of study test lens to study control lens, when worn on a daily disposable modality over a period of approximately one week each

NCT ID: NCT04476784 Completed - Myopia Clinical Trials

Clinical Assessment of a Daily Wear Monthly Replacement Soft Silicone Hydrogel Contact Lens

Start date: August 17, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the clinical performance of an investigational contact lens over 30 days of daily wear.

NCT ID: NCT04452448 Completed - Myopia Clinical Trials

Analysis of I-Trace High Order Aberrations Induced by Wavefront Optimized Ablation Profiles

Start date: January 10, 2018
Phase: Phase 2/Phase 3
Study type: Interventional

This work aims at the analysis of ocular aberrations induced by wave front optimized ablation profiles WFO using I-Trace aberrometer (Ray -Tracing)

NCT ID: NCT04443231 Completed - Myopia Clinical Trials

Prospective Clinical Study of Retinal Microvascular Alteration After ICL Implantation

Start date: November 1, 2018
Phase:
Study type: Observational

To observe the retinal microvascular alteration during 3 months follow-up after Implantable Collamer Lens (ICL) operation in moderate and high myopia patients using quantitative optical coherence tomography angiography (OCTA) analysis.

NCT ID: NCT04426175 Completed - Myopia Clinical Trials

Z8 OCT-controlled 2D vs 3D LASIK

Start date: December 5, 2019
Phase: N/A
Study type: Interventional

The aim of this study was to test the hypothesis that OCT-guided 110 µm targeted flaps will result in accurate, predictable, and precise thickness flaps, with low complication rates when performed and compared using both 2D and 3D flap geometry applications and how it correlated to visual experience and quality of life responses during the early postoperative period.